Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02906371
Title Study of the Tocilizumab Optimization Timing for CART19 Associated Cytokine Release Syndrome
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Pennsylvania
Indications

acute lymphoblastic leukemia

lymphoblastic lymphoma

Therapies

Tocilizumab

Age Groups: child | adult
Covered Countries USA

Facility Status City State Zip Country Details
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field